Mark Dybul Enochian Biosciences Inc (ENOB) insider trading activity
Mark Dybul is Chief Executive Officer of Enochian Biosciences Inc. Currently has a direct ownership of 66,196 shares of ENOB, which is worth approximately $304,501. The most recent transaction as insider was on Dec 14, 2020, when has been sold 180 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
66.2K
0%
3M change
0%
12M change
Total Value Held
$304,501
MD
Mark Dybul
Chief Executive Officer
Chestertown, MD